Halozyme sec filings
WebThe patient is at the forefront of everything we do at Halozyme. With our disruptive drug delivery technologies and robust commercial portfolio, we are committed to reinventing the patient experience by easing the burden of treatment and improving patient outcomes. WebFeb 21, 2024 · SEC Filings Halozyme Therapeutics Inc (HALO) 10-K Annual Report Tue Feb 21 2024 Earnings Press Release 10-K Annual Report 10-K YoY Changes …
Halozyme sec filings
Did you know?
Web2 days ago · Halozyme's drug delivery technology, called Enhanze, enables the subcutaneous delivery of biological drugs. Biologics are large, complex molecules … WebMar 24, 2024 · At Halozyme Therapeutics, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below.
WebApr 10, 2024 · Park Avenue Securities LLC’s holdings in Halozyme Therapeutics were worth $436,000 as of its most recent filing with the Securities & Exchange Commission. … WebView 13F filing holders of Halozyme Therapeutics Inc. 13F filings are submitted quarterly to the SEC by hedge funds and other investment managers. WhaleWisdom ... Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 ...
WebMar 29, 2024 · SEC filings and transcripts for Halozyme Therapeutics Inc., including financials, news, proxies, indentures, ... 6 Halozyme Therapeutics Inc. Expert Interviews, now on BamSEC. ... Letter from the SEC 01/29/16 CORRESP Correspondence with the SEC 01/04/16 ... WebNov 8, 2024 · Halozyme Therapeutics, Inc. (HALO) SEC Filing 8-K Material Event for the period ending Tuesday, November 8, 2024. Home. SEC Filings. ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word …
WebMar 29, 2024 · Halozyme Therapeutics Inc. – Filings and Transcripts – BamSEC Halozyme Therapeutics Inc. Watch NASDAQ: HALO Share price (3/10/23): $41.63 …
WebAnalyst Coverage. Halozyme Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Halozyme Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Halozyme Therapeutics, Inc. or its management. faiz brothers pvt ltdWebApr 13, 2024 · Strs Ohio cut its stake in Halozyme Therapeutics, Inc. ( NASDAQ:HALO – Get Rating) by 39.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities ... faiz hameed wikipediadollar general halloween shirtsWebArchived Events & Presentations. 03/09/2024. Corporate Presentation. Presentation. 02/21/2024 04:30 PM ET. Halozyme to Host Fourth Quarter 2024 Financial Results Conference Call. Webcast. Presentation. Press Release. dollar general hartstown paWebApr 13, 2024 · Strs Ohio cut its stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Get Rating) by 39.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.The fund owned 26,500 shares of the biopharmaceutical company's stock after selling 17,500 shares during the quarter. dollar general haworth okWebHalozyme Therapeutics, Inc. Common Stock (HALO) SEC Filings Nasdaq SEC Filings: HALO Edit my quotes Halozyme Therapeutics, Inc. Common Stock (HALO) Add to … dollar general hawley pa hoursWebClose. Log-In Home E-mail Alerts My Headlines Portfolio; Home; Menu. JOIN; SI Premium; Ratings; Mergers; Earnings; Dividends dollar general hard plastic pool